NDC Package 69097-078-97 Potassium Phosphates

Injection Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
69097-078-97
Package Description:
25 VIAL in 1 CARTON / 5 mL in 1 VIAL (69097-078-67)
Product Code:
Proprietary Name:
Potassium Phosphates
Non-Proprietary Name:
Potassium Phosphates
Substance Name:
Dibasic Potassium Phosphate; Monobasic Potassium Phosphate
Usage Information:
Potassium phosphates injection is indicated as a source of phosphorus:in intravenous fluids to correct hypophosphatemia in adults and pediatric patients when oral or enteral replacement is not possible, insufficient or contraindicated.for parenteral nutrition in adults and pediatric patients when oral or enteral nutrition is not possible, insufficient or contraindicated.   
11-Digit NDC Billing Format:
69097007897
NDC to RxNorm Crosswalk:
  • RxCUI: 1928567 - potassium phosphates (phosphorus 15 MMOL / potassium 22 MEQ) in 5 ML Injection
  • RxCUI: 1928567 - 5 ML dibasic potassium phosphate 236 MG/ML / monobasic potassium phosphate 224 MG/ML Injection
  • RxCUI: 1928567 - 5 ML Dibasic K+ phosphate 236 MG/ML / Monobasic K+ phosphate 224 MG/ML Injection
  • RxCUI: 1928567 - 5 ML Dibasic Pot phosphate 236 MG/ML / Monobasic Pot phosphate 224 MG/ML Injection
  • RxCUI: 1928567 - phosphorus 15 MMOL / potassium 22 MEQ per 5 ML Injection
Product Type:
Human Prescription Drug
Labeler Name:
Cipla Usa Inc.
Dosage Form:
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route(s):
Intravenous - Administration within or into a vein or veins.
Sample Package:
No
FDA Application Number:
ANDA217892
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
02-06-2025
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 69097-078-97?

The NDC Packaged Code 69097-078-97 is assigned to a package of 25 vial in 1 carton / 5 ml in 1 vial (69097-078-67) of Potassium Phosphates, a human prescription drug labeled by Cipla Usa Inc.. The product's dosage form is injection and is administered via intravenous form.

Is NDC 69097-078 included in the NDC Directory?

Yes, Potassium Phosphates with product code 69097-078 is active and included in the NDC Directory. The product was first marketed by Cipla Usa Inc. on February 06, 2025 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 69097-078-97?

The 11-digit format is 69097007897. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-269097-078-975-4-269097-0078-97